Pediatric Growth Hormone Deficiency

Explore clinical trials studying Pediatric Growth Hormone Deficiency. Study availability and eligibility vary by location and protocol.

7 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Pediatric Growth Hormone Deficiency trial results

Not Yet Recruiting

A Study of GenSci134 in Children With Growth Hormone Deficiency (PGHD)

NCT07450001

Conditions: Pediatric Growth Hormone Deficiency
Locations: Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology Wuhan, Hubei, China

View Trial Details

Not Yet Recruiting

A Study (Phase 1b/2) of GS3-007a Oral Treatment in Children With Growth Hormone Deficiency (PGHD)

NCT07264595

Conditions: Pediatric Growth Hormone Deficiency
Locations: Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology Wuhan, Hubei, China

View Trial Details

Completed

Safety and Efficacy Phase 3 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children

NCT02968004

Conditions: Pediatric Growth Hormone Deficiency
Locations: Children's Hospital of Orange County- Children's Clinic Orange, California, United States

Children's Hospital- Colorado Aurora, Colorado, United States

Rocky Mountain Pediatrics Centennial, Colorado, United States

Nemours Children's Health System Jacksonville, Florida, United States

View all 81 locations

View Trial Details

Completed

A Study to Evaluating the Efficacy and Safety of Recombinant Long-acting Human Growth Hormone (TJ101) in Children With Growth Hormone Deficiency

NCT04633057

Conditions: Pediatric Growth Hormone Deficiency
Locations: Second Affiliated Hospital of Anhui Medical University Hefei, Anhui, China

Beijing Children's Hospital,Capital Medical University Beijing, Beijing Municipality, China

Children's Hospital, Capital Institute of Paediatrics Beijing, Beijing Municipality, China

Chongqing Three Gorges Central Hospital Wanzhou, Chongqing Municipality, China

View all 30 locations

View Trial Details

Completed

Versartis Trial in Children to Assess Long-Acting Growth Hormone

NCT01718041

Conditions: Bone Diseases, Bone Diseases, Developmental, Bone Diseases, Endocrine, +11 more
Locations: Clovis, California, United States

Los Angeles, California, United States

San Diego, California, United States

San Francisco, California, United States

View all 23 locations

View Trial Details

Completed

Safety and Efficacy Phase 2 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children

NCT01592500

Conditions: Pediatric Growth Hormone Deficiency
Locations: Children's Hospital "P. A. Kyriakou" Athens, Greece

Buda Children's Hospital Budapest, Hungary

Heim Pal Children's Hospital Budapest, Hungary

Children's University Hospital Košice, Slovakia

View Trial Details

Active, Not Recruiting

Korean Post-marketing Surveillance Ngenla® Pre-filled Pen Injection for the Treatment of Pediatric Patients With Growth Disturbance Due to Insufficient Secretion of Growth Hormone

NCT05509894

Conditions: Pediatric Growth Hormone Deficiency
Locations: Pfizer Seoul, South Korea

View Trial Details

Pediatric Growth Hormone Deficiency

Pediatric Growth Hormone Deficiency trial results

A Study of GenSci134 in Children With Growth Hormone Deficiency (PGHD)

A Study (Phase 1b/2) of GS3-007a Oral Treatment in Children With Growth Hormone Deficiency (PGHD)

Safety and Efficacy Phase 3 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children

A Study to Evaluating the Efficacy and Safety of Recombinant Long-acting Human Growth Hormone (TJ101) in Children With Growth Hormone Deficiency

Versartis Trial in Children to Assess Long-Acting Growth Hormone

Safety and Efficacy Phase 2 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children

Korean Post-marketing Surveillance Ngenla® Pre-filled Pen Injection for the Treatment of Pediatric Patients With Growth Disturbance Due to Insufficient Secretion of Growth Hormone

Related conditions